BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12088204)

  • 1. Detection of micrometastatic cells in breast cancer by RT-pCR for the mammaglobin gene.
    Bossolasco P; Ricci C; Farina G; Soligo D; Pedretti D; Scanni A; Deliliers GL
    Cancer Detect Prev; 2002; 26(1):60-3. PubMed ID: 12088204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer.
    Corradini P; Voena C; Astolfi M; Delloro S; Pilotti S; Arrigoni G; Bregni M; Pileri A; Gianni AM
    Ann Oncol; 2001 Dec; 12(12):1693-8. PubMed ID: 11843246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mammaglobin RT-PCR assay for detection of occult breast cancer cells in hematopoietic products.
    Silva AL; Tomé MJ; Correia AE; Passos-Coelho JL
    Ann Oncol; 2002 Mar; 13(3):422-9. PubMed ID: 11996474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer.
    Ooka M; Tamaki Y; Sakita I; Fujiwara Y; Yamamoto H; Miyake Y; Sekimoto M; Ohue M; Sugita Y; Miyoshi Y; Ikeda N; Noguchi S; Monden M
    Breast Cancer Res Treat; 2001 May; 67(2):169-75. PubMed ID: 11519865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of disseminated carcinoma cells in bone marrow and peripheral blood in primary breast cancer with RT/PCR of parathyroid hormone-related protein (PTHrP)].
    Liersch T; Gatzemeier W; Scharnberg P; Jürgens B; Wörmann B; Becker H; Rauschecker HF; Hiddemann W; Wulf GG
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):277-80. PubMed ID: 14518259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
    Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
    Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly sensitive detection of the MGB1 transcript (mammaglobin) in the peripheral blood of breast cancer patients.
    Cerveira N; Torres L; Rocha P; Bizarro S; Pereira D; Abreu J; Henrique R; Teixeira MR; Castedo S
    Int J Cancer; 2004 Feb; 108(4):592-5. PubMed ID: 14696125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
    Ghaffari SR; Sabokbar T; Tahmasebi S; Dastan J; Shorakae S; Moradi A; Tirgari F; Mohagheghi MA; Mosavi-Jarrahi A
    Asian Pac J Cancer Prev; 2006; 7(3):396-8. PubMed ID: 17059329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse transcriptase/polymerase chain reaction analysis of parathyroid hormone-related protein for the detection of tumor cell dissemination in the peripheral blood and bone marrow of patients with breast cancer.
    Wulf GG; Jürgens B; Liersch T; Gatzemeier W; Rauschecker H; Buske C; Hüfner M; Hiddemann W; Wörmann B
    J Cancer Res Clin Oncol; 1997; 123(9):514-21. PubMed ID: 9341902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
    Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
    Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.
    Benoy IH; Elst H; Philips M; Wuyts H; Van Dam P; Scharpé S; Van Marck E; Vermeulen PB; Dirix LY
    Clin Breast Cancer; 2006 Jun; 7(2):146-52. PubMed ID: 16800974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
    Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
    Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small subgroup of operable breast cancer patients with poor prognosis identified by quantitative real-time RT-PCR detection of mammaglobin A and trefoil factor 1 mRNA expression in bone marrow.
    Tjensvoll K; Gilje B; Oltedal S; Shammas VF; Kvaløy JT; Heikkilä R; Nordgård O
    Breast Cancer Res Treat; 2009 Jul; 116(2):329-38. PubMed ID: 18846421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer.
    Fleming TP; Watson MA
    Ann N Y Acad Sci; 2000; 923():78-89. PubMed ID: 11193781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.
    Aihara T; Fujiwara Y; Ooka M; Sakita I; Tamaki Y; Monden M
    Breast Cancer Res Treat; 1999 Nov; 58(2):137-40. PubMed ID: 10674878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammaglobin RT-qPCR for breast cancer metastasis detection in sentinel lymph nodes.
    Span PN; Van Laarhoven HW; Sweep FC
    Cancer Sci; 2010 Nov; 101(11):2501; author reply 2502. PubMed ID: 20950374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of cytokeratin 19, human mammaglobin, and carcinoembryonic antigen-positive circulating tumor cells by three-marker reverse transcription-PCR assay and its relation to clinical outcome in early breast cancer.
    Chen Y; Zou TN; Wu ZP; Zhou YC; Gu YL; Liu X; Jin CG; Wang XC
    Int J Biol Markers; 2010; 25(2):59-68. PubMed ID: 20586026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammaglobin as a marker for the detection of tumor cells in the peripheral blood of breast cancer patients.
    Zach O; Kasparu H; Wagner H; Krieger O; Lutz D
    Ann N Y Acad Sci; 2000; 923():343-5. PubMed ID: 11193775
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of mammaglobin mRNA in the plasma of breast cancer patients.
    Gal S; Fidler C; Lo YM; Chin K; Moore J; Harris AL; Wainscoat JS
    Ann N Y Acad Sci; 2001 Sep; 945():192-4. PubMed ID: 11708478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.